Primary systemic therapy by dual HER2 blockage with lapatinib (La) plus trastuzumab (T) for Japanese patients (pts) with HER2+breast cancer (BC): Association of La toxicity and dose with treatment efficacy
Yamashita,T; Masuda,N; Yamamoto,N; Kondo,N; Bando,H; Akiyoshi,S; Ohtani,S; Takano,T; Inoue,K; Fujisawa,T; Ishiguro,H; Nakayama,H; Aogi,K; Amano,S; Ozaki,H; Yasojima,H; Kasai,H; Kataoka,T. R; Morita,S; Toi,M
EUROPEAN JOURNAL OF CANCER, 2015年09月, 査読有り